| Ticker: | ECOR |
| Current Price: | $5.25 |
| % Daily Change: | -0.76% |
| Volume (1,000s): | 290.84 |
| Average Volume (1,000s): | 113.19 |
| Market Cap (M): | $48.44 |
| 1/2/2024 Price: | $5.97 |
| Change Since Inception: | -12.06% |
150 Allen Road
Suite 201
Basking Ridge, NJ 07920
United States
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of patient administered non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.